Survivorship: Immunizations and Prevention of Infections, Version 2.2014

Restricted access

Cancer survivors are at an elevated risk for infection because of immune suppression associated with prior cancer treatments, and they are at increased risk of complications from vaccine-preventable diseases. This section of the NCCN Guidelines for Survivorship provides recommendations for the prevention of infections in survivors through education, antimicrobial prophylaxis, and the judicious use of vaccines. These guidelines provide information about travel and gardening precautions and safe pet care/avoidance of zoonosis, and include detailed recommendations regarding vaccinations that should be considered and encouraged in cancer and transplant survivors.

  • 1.

    Kwon HJ, Lee JW, Chung NG. Assessment of serologic immunity to diphtheria-tetanus-pertussis after treatment of Korean pediatric hematology and oncology patients. J Korean Med Sci 2012;27:7883.

    • Search Google Scholar
    • Export Citation
  • 2.

    Ljungman P, Cordonnier C, Einsele H. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009;44:521526.

  • 3.

    Klosky JL, Gamble HL, Spunt SL. Human papillomavirus vaccination in survivors of childhood cancer. Cancer 2009;115:56275636.

  • 4.

    Underwood JM, Townsend JS, Stewart SL. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 2012;61:123.

    • Search Google Scholar
    • Export Citation
  • 5.

    Snyder CF, Frick KD, Peairs KS. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med 2009;24:469474.

    • Search Google Scholar
    • Export Citation
  • 6.

    Locher JL, Rucks AC, Spencer SA. Influenza immunization in older adults with and without cancer. J Am Geriatr Soc 2012;60:20992103.

  • 7.

    Small TN, Zelenetz AD, Noy A. Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2009;15:15381542.

    • Search Google Scholar
    • Export Citation
  • 8.

    Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007;33:124.

    • Search Google Scholar
    • Export Citation
  • 9.

    Gradel KO, Norgaard M, Dethlefsen C. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study. Ann Hematol 2009;88:761767.

    • Search Google Scholar
    • Export Citation
  • 10.

    Lortholary O, Charlier C, Lebeaux D. Fungal infections in immunocompromised travelers. Clin Infect Dis 2013;56:861869.

  • 11.

    Mani I, Maguire JH. Small animal zoonoses and immuncompromised pet owners. Top Companion Anim Med 2009;24:164174.

  • 12.

    Partridge-Hinckley K, Liddell GM, Almyroudis NG, Segal BH. Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients. Mycopathologia 2009;168:329337.

    • Search Google Scholar
    • Export Citation
  • 13.

    Visser LG. The immunosuppressed traveler. Infect Dis Clin North Am 2012;26:609624.

  • 14.

    National Center for Immunization and Respiratory Diseases. General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:164.

    • Search Google Scholar
    • Export Citation
  • 15.

    Bridges CB, Coyne-Beasley T; Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2014. Ann Intern Med 2014;160:190.

    • Search Google Scholar
    • Export Citation
  • 16.

    Rubin LG, Levin MJ, Ljungman P. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58:309318.

    • Search Google Scholar
    • Export Citation
  • 17.

    Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older—United States, 2013. MMWR Surveill Summ 2013;62(Suppl 1):1.

    • Search Google Scholar
    • Export Citation
  • 18.

    Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2013*. Ann Intern Med 2013;158:191199.

    • Search Google Scholar
    • Export Citation
  • 19.

    Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816819.

    • Search Google Scholar
    • Export Citation
  • 20.

    Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices—United States, 2013-2014. MMWR Recomm Rep 2013;62:143.

    • Search Google Scholar
    • Export Citation
  • 21.

    Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:130; quiz CE32-34.

    • Search Google Scholar
    • Export Citation
  • 22.

    Weaver BA; Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention. Update on the advisory committee on immunization practices’ recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc 2011;111:S3133.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 163 126 1
PDF Downloads 31 25 0
EPUB Downloads 0 0 0